Literature DB >> 12987553

Inhibition of tumour-growth after oral and parenteral treatment with nitrogen mustards and triethylene malamine.

O PECZENIK.   

Abstract

Entities:  

Keywords:  NEOPLASMS/experimental; NITROGEN MUSTARDS/effects; TRIETHYLENE MELAMINE/effects

Mesh：

Substances：

Year:  1952        PMID： 12987553      PMCID： PMC2007836          DOI： 10.1038/bjc.1952.31

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  Treatment of rheumatoid arthritis with nitrogen mustard; preliminary report.

Authors:  C JIMENEZ DIAZ; E LOPEZ GARCIA; A MERCHANTE; J PERIANES
Journal:  J Am Med Assoc       Date:  1951-12-08

2.  Cytotoxic agents: III, derivatives of ethyleneimine.

Authors:  J A HENDRY; R F HOMER; F L ROSE; A L WALPOLE
Journal:  Br J Pharmacol Chemother       Date:  1951-09

3.  Further observations on tumour cells in the paramorphic or dormant resistant state.

Authors:  J CRAIGIE
Journal:  J Pathol Bacteriol       Date:  1952-01

4.  Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors:  D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal:  AMA Arch Intern Med       Date:  1951-04

5.  Aspects of approaches in experimental cancer chemotherapy.

Authors:  C C STOCK
Journal:  Am J Med       Date:  1950-05       Impact factor: 4.965
  5 in total
  1 in total

1.  The development of resistance in the Walker carcinosarcoma to the action of triethylene melamine.

Authors:  H JACKSON
Journal:  Br J Cancer       Date:  1954-06       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.